This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
HealthdirectFree Australian health advice you can count on. — Description, Dosage, Side Effects | PillsCard
OTC
HealthdirectFree Australian health advice you can count on.
INN: azacitidine
Data updated: 2026-04-25
Available in:
🇨🇿🇬🇧🇫🇷🇸🇰
Form
—
Dosage
—
Route
—
Storage
—
About This Product
Manufacturer
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Mylan Pharmaceuticals Limited
ATC Code
L01BC07
Source
EMA · EMEA/H/C/004984
(
ARTG
)
Azacitidine ANS is indicated for the treatment of patients with:, Intermediate-2 and High-risk Myelodysplastic Syndromes (MDS) according to the International Prognostic Scoring System (IPSS),, Chronic Myelomonocytic Leukaemia [CMMoL (10-29 percent marrow blasts without Myeloproliferative Disorder)],, Acute Myeloid Leukaemia (AML) with 20-30 percent blasts and multi-lineage dysplasia, according to World Health Organisation Classification (WHO),,in whom allogenic stem cell transplantation is not indicated.
⚠️ Warnings
• Caution should be exercised in patients with history of kidney or liver problems, any allergy, who are taking other medication, elderly, children, during pregnancy and breastfeeding.
• It may cause dizziness, fainting, or lightheadedness, do not drive a car or operate machinery and get up slowly from bed while taking this medication.
• It may reduce platelet counts; avoid injury or bruising.
• Monitor liver, kidney functions, and blood cell counts regularly while taking this medication.
• Avoid contact with people who have infections.
